337 related articles for article (PubMed ID: 12395898)
21. Mixed acinar-endocrine carcinoma of the pancreas--a case report.
Cho KJ; Kim JY; Lee SS; Khang SK; Kim CW
J Korean Med Sci; 1996 Apr; 11(2):188-92. PubMed ID: 8835769
[TBL] [Abstract][Full Text] [Related]
22. Duct-acinar-islet cell tumor of the pancreas.
Nonomura A; Kono N; Mizukami Y; Nakanuma Y; Matsubara F
Ultrastruct Pathol; 1992; 16(3):317-29. PubMed ID: 1316659
[TBL] [Abstract][Full Text] [Related]
23. Cell lineage markers in human pancreatic cancer.
Kim JH; Ho SB; Montgomery CK; Kim YS
Cancer; 1990 Nov; 66(10):2134-43. PubMed ID: 2224768
[TBL] [Abstract][Full Text] [Related]
24. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic carcinoma with duct, endocrine, and acinar differentiation. A histologic, immunocytochemical, and ultrastructural study.
Schron DS; Mendelsohn G
Cancer; 1984 Nov; 54(9):1766-70. PubMed ID: 6089999
[TBL] [Abstract][Full Text] [Related]
26. Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases.
Kardon DE; Thompson LD; Przygodzki RM; Heffess CS
Mod Pathol; 2001 May; 14(5):443-51. PubMed ID: 11353055
[TBL] [Abstract][Full Text] [Related]
27. Solid adenoma with exclusive hepatocellular differentiation: a new variant among pancreatic benign neoplasms?
Cuilliere P; Lazure T; Bui M; Fabre M; Buffet C; Gayral F; Bedossa P
Virchows Arch; 2002 Nov; 441(5):519-22. PubMed ID: 12447684
[TBL] [Abstract][Full Text] [Related]
28. [Value of cytokeratin and Ca 19-9 antigen in immunohistological detection of disseminated tumor cells in lymph nodes in pancreas carcinoma].
Ridwelski K; Meyer F; Fahlke J; Kasper U; Roessner A; Lippert H
Chirurg; 2001 Aug; 72(8):920-6. PubMed ID: 11554137
[TBL] [Abstract][Full Text] [Related]
29. The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma.
Yasumoto M; Hamabashiri M; Akiba J; Ogasawara S; Naito Y; Taira T; Nakayama M; Daicho A; Yamasaki F; Shimamatsu K; Ishida Y; Kaji R; Okabe Y; Nakashima O; Ohshima K; Nakashima M; Sata M; Yano H
J Clin Pathol; 2012 Apr; 65(4):327-32. PubMed ID: 22228907
[TBL] [Abstract][Full Text] [Related]
30. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid.
Sawhney MS; Devarajan S; O'Farrel P; Cury MS; Kundu R; Vollmer CM; Brown A; Chuttani R; Pleskow DK
Gastrointest Endosc; 2009 May; 69(6):1106-10. PubMed ID: 19249035
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.
Roldo C; Missiaglia E; Hagan JP; Falconi M; Capelli P; Bersani S; Calin GA; Volinia S; Liu CG; Scarpa A; Croce CM
J Clin Oncol; 2006 Oct; 24(29):4677-84. PubMed ID: 16966691
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic ductal adenocarcinomas with cystic features: neither rare nor uniform.
Kosmahl M; Pauser U; Anlauf M; Klöppel G
Mod Pathol; 2005 Sep; 18(9):1157-64. PubMed ID: 15920540
[TBL] [Abstract][Full Text] [Related]
33. Mixed acinar-neuroendocrine-ductal carcinoma of the pancreas: a tale of three lineages.
Anderson MJ; Kwong CA; Atieh M; Pappas SG
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27257019
[TBL] [Abstract][Full Text] [Related]
34. Mixed ductal-pancreatic polypeptide-cell carcinoma of the pancreas.
Chatelain D; Parc Y; Christin-Maitre S; Parc R; Flejou JF
Histopathology; 2002 Aug; 41(2):122-6. PubMed ID: 12147089
[TBL] [Abstract][Full Text] [Related]
35. Mixed acinar-endocrine carcinoma of the pancreas: new clinical and pathological features in a contemporary series.
Yu R; Jih L; Zhai J; Nissen NN; Colquhoun S; Wolin E; Dhall D
Pancreas; 2013 Apr; 42(3):429-35. PubMed ID: 23462323
[TBL] [Abstract][Full Text] [Related]
36. Mixed duct-acinar-islet cell tumor of the pancreas: report of a case.
Tanakaya K; Teramoto N; Konaga E; Takeuchi H; Yasui Y; Takeda A; Yunoki Y; Murakami I
Surg Today; 2001; 31(2):177-9. PubMed ID: 11291717
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic Ductal Adenocarcinoma in Remnant Pancreas after Pancreaticoduodenectomy for Acinar Cell Carcinoma: A Case Report.
Nishimura S; Utsumi M; Aoki H; Une Y; Kashima H; Kimura Y; Taniguchi F; Arata T; Katsuda K; Tanakaya K; Sato Y
J Nippon Med Sch; 2019 Dec; 86(5):279-283. PubMed ID: 31061255
[TBL] [Abstract][Full Text] [Related]
38. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma.
Grützmann R; Lüttges J; Sipos B; Ammerpohl O; Dobrowolski F; Alldinger I; Kersting S; Ockert D; Koch R; Kalthoff H; Schackert HK; Saeger HD; Klöppel G; Pilarsky C
Br J Cancer; 2004 Mar; 90(5):1053-8. PubMed ID: 14997207
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations.
Schaeffer BK; Terhune PG; Longnecker DS
Am J Pathol; 1994 Sep; 145(3):696-701. PubMed ID: 8080049
[TBL] [Abstract][Full Text] [Related]
40. Expression of human regenerating gene mRNA and its product in normal and neoplastic human pancreas.
Kimura N; Yonekura H; Okamoto H; Nagura H
Cancer; 1992 Oct; 70(7):1857-63. PubMed ID: 1525759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
